Biomarcadores sanguíneos en la enfermedad de Alzheimer
Authors:
- M. Altuna-AzkargortaMAM. Altuna-Azkargorta
- M. Mendioroz-IriarteMMM. Mendioroz-Iriarte
Open Access
- 1 November 2021
- journal article
- Published by Elsevier in Neurología
- Vol. 36 (9) , 704-710
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on AgingJAMA Neurology, 2017
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology, 2017
- Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and designAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2017
- Blood‐based metabolic signatures in Alzheimer's diseaseAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2017
- Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohortAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2017
- Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkersAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2016
- The future of blood‐based biomarkers for Alzheimer's diseaseAlzheimer's & Dementia, 2013
- Blood-Based Protein Biomarkers for Diagnosis of Alzheimer DiseaseArchives of Neurology, 2012
- Dissociated amyloid-β antibody levels as a serum biomarker for the progression of Alzheimer’s disease: A population-based studyExperimental Gerontology, 2010
- Blood-based biomarkers of microvascular pathology in Alzheimer’s diseaseExperimental Gerontology, 2010